Polypharmacy and the Risk of Adverse Drug Reactions in the Elderly at a Tertiary Referral Hospital in Indonesia: Assessing the Applicability of the GerontoNet Score
Keywords:
adverse drug reaction, geriatrics, GerontoNet scores, polypharmacyAbstract
Background: Geriatric patients are often subject to polypharmacy, increasing their risk of adverse drug reactions (ADRs). This study evaluated polypharmacy practices, ADR incidence, predictive factors, and the applicability of the GerontoNet Score at a tertiary referral teaching hospital in Indonesia. Methods: This retrospective study included 340 geriatric inpatients at Dr. Cipto Mangunkusumo Hospital, Jakarta, in 2023. The relationship between demographic data, comorbidities, number of drugs used, and ADR events was analyzed using the Chi-square test. The association between GerontoNet ADR scores and ADR events was also assessed. Results: The study included 182 (53.5%) male and 158 (46.5%) female patients, with a mean age of 71.9±6.1 years. Of these, 70.9% were aged 65 to 74. A total of 78.8% of patients had ≥ 4 comorbidities. The number of drugs ranged from 3 to 28, with a mean of 10.7 drugs and a median of 10 drugs. ADRs were detected in 26 patients (7.6%), with 17 cases in females and 9 in males (p=0.044). Insulin- and diuretic-induced hypokalemia were the most frequent ADR (13 patients), followed by heparin-induced thrombocytopenia (3 patients). No significant correlation was found between ADRs and age (p=0.505), number of comorbidities (p=0.425), number of drugs (p=0.576), or GerontoNet ADR Score (p=0.530). Conclusion: Polypharmacy is prevalent at Dr. Cipto Mangunkusumo Hospital, yet the incidence of ADRs is relatively low. Most ADRs were related to high-alert drugs, while no significant correlations were found between age, polypharmacy, comorbidities, or GerontoNet Score with ADR events.References
World Health Organization (2016). Developing pharmacy practice—A focus on patient care. Department of Medicines Policy and Standards; International Pharmaceutical Federation. Geneva, Switzerland: WHO.
Ni XF, Yang CS, Bai YM, Hu ZX, Zhang LL. Drug-related problems of patients in Primary Health Care Institutions: A Systematic Review. Front Pharmacol. 2021;12:698907.
Paisansirikul A, Ketprayoon A, Ittiwattanakul W, Petchlorlian A. Prevalence and associated factors of drug related problems among older people: A cross sectional study at King Chulalongkorn Memorial Hospital in Bangkok. Drugs - Real World Outcomes (2021) 8:73-84. Doi:10.1007/s40801-020-00219-2.
Sharon T, Vemparala C, Kandukuri SV, Komati M, Gottapu B. Incidence of polypharmacy and drug-related problems among elderly in tertiary care hospital-A descriptive study. Asian J Pharm Clin Res. 2022;15(9):140-4. doi:10.22159/ajpcr.2022v15i9.44618.
Sefera B, Getachew M, Babu Y, Bekele F, Fanta K. Drug-related problems and its predictors among hospitalized heart failure patients at Jimma Medical Center, South West Ethiopia: prospective interventional study. BMC Cardiovasc Disord. 2022;22(1):418-29. doi: 10.1186/s12872-022-02859-4.
Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older. The GerontoNet ADR risk score. Arch Intern Med. 2010;170(13):1142-8.
Al-Ragawi A, Zyryanov S, Ushkalova E, Butranova O, Pereverzev A. Prediction of ADRs and estimation of polypharmacy in older patient’s population: Retrospective study in Russian Gerontology Center. OBM Geriatrics. 2019;3(1), doi:10.21926/obm.geriatr.1901038.
Borah L, Devi D, Debnath PK, Deka D. A study of drug utilization pattern of the geriatric patients in the department of geriatric medicine in a tertiary care hospital in Assam, India. Asian J Pharm Clin Res. 2017; 10(2):122-6. doi:10.22159/ajpcr.2017.v10i2.14762.
Coregliano-Ring L, Goia-Nishide K, Rangel ÉB. Hypokalemia in diabetes mellitus setting. Medicina (Kaunas). 2022;58(3):431. doi: 10.3390/medicina58030431. PMID: 35334607; PMCID: PMC8954285.
Benowitz NL. Antihypertensive agents. In. Katzung BG (ed). Basic and clinical pharmacology. 4th ed. New York: McGraw Hill; 2018. p. 173-276.
Jackson EK, Drug affecting renal excretory function. In: Bruntol LL, (eds). Goodman and Gilman’s the pharmacological basis of therapeutics. 14th ed. New York: McGraw-Hill; 2023. p. 557-84.
Tajuddin H, Wahyudin E, Djabir YY, Nainu F, Rahman L. Insulin therapy increases the risk of hypokalemia and arrhythmia in diabetic patients with coronary heart disease: A retrospective study in Wahidin Sudirohusodo General Hospital. Galenika Journal of Pharmacy. 2022;8(2):97–108. doi: 10.22487/j24428744.2022.v8.i2.15930
Hefner G, Hahn M, Roll SC, Klimke A, Hiemke C. Application of the GerontoNet ADR risk score in a psychiatric setting. International Journal of Clinical Medicine Research. 2018;5(1):7-14.
Petrovic M, Tangiisuran B, Rajkumar C, van der Cammen T, Onder G. Predicting the risk of adverse drug reactions in older inpatients: External validation of the GerontoNet ADR risk score using the CRIME cohort. Drugs Aging. 2017;34:135-42. doi: 10.1007/s40266-016-0428-4
Stevenson JM, Williams JI, Burnham TG, et al. Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models. Clinical Interventions in Aging. 2014:9 1581-93.
Atmaja DS, Yulistiani, Suharjono, Zairina E. Detection tools for prediction and identification of adverse drug reactions in older patients: a systematic review and meta analysis. Nature. 2022;12:13189. doi: 10.1038/s41598-022-17410-w.
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.